Related Experiment Video
Updated: Jul 30, 2025

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
Chronic kidney disease-associated pruritus: what is known and its application in children
Shweta Shah1, Elizabeth Onugha2, Sarah J Swartz2
1Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA. ssshah@texaschildrens.org.
Insights
Chronic kidney disease-associated pruritus (CKD-aP), or uremic pruritus, significantly impacts dialysis patients. Early recognition and treatment in children are crucial due to limited data and available therapies.
Area of Science:
- Nephrology
- Dermatology
- Pediatrics
Background:
- Chronic kidney disease-associated pruritus (CKD-aP), also known as uremic pruritus, is a common and severe symptom in patients with kidney failure undergoing kidney replacement therapy.
- Severe pruritus in dialysis patients is linked to adverse outcomes and significantly diminishes quality of life.
- Limited data exists regarding CKD-aP specifically in pediatric populations.
Purpose of the Study:
- To review the current understanding of CKD-aP epidemiology, clinical features, assessment tools, and treatment options.
- To highlight the importance of recognizing and managing pruritus in children with chronic kidney disease.
- To emphasize the need for better-studied therapeutic interventions for pediatric CKD-aP.
Main Methods:
- Literature review of epidemiology, clinical characteristics, pruritus scoring systems, and therapeutic options for CKD-aP.
- Focus on data relevant to patients with chronic kidney disease and those on dialysis.
- Specific attention to the pediatric population and the scarcity of research therein.
Main Results:
- CKD-aP is multifactorial, impacts quality of life, and correlates with poor outcomes in dialysis patients.
- Optimizing dialysis and correcting electrolyte imbalances are key management strategies.
- A range of treatments exist, but few are well-studied in children.
Conclusions:
- Optimal management of CKD-aP requires awareness of symptom severity and impact on quality of life.
- Earlier recognition and treatment of pruritus in children with chronic kidney disease are imperative.
- Further research is needed to establish effective and well-studied treatments for pediatric CKD-aP.
Abstract:
Chronic kidney disease-associated pruritus (CKD-aP) or uremic pruritus (UP) is a frequent symptom in patients with kidney failure receiving kidney replacement therapy. Severe chronic kidney disease-associated pruritus correlates with poor outcome in patients on dialysis. It is multifactorial in etiology and has a significant impact on quality of life. There is, however, limited data for children. This review summarizes current epidemiology, clinical characteristics, pruritus scoring systems, and available therapeutic options for pruritus in patients with chronic kidney disease and those receiving dialysis. Optimal care requires proper awareness of the severity of symptoms, the impact on quality of life, and the possible long-term outcomes. Optimizing dialysis prescription and correcting electrolyte abnormalities are important treatment targets. A wide range of therapeutic options is also available although none are well-studied in children. An earlier recognition of this debilitating symptom in children and treatment is imperative. A higher resolution version of the Graphical abstract is available as Supplementary information.
More Related Videos
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management